Announcements Trials
Browse Landscape

Phase

Phase 1 23Phase 1/2 6Phase NA 5Phase 2 5Phase EARLY_PHASE1 3Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 71Thoracic 2Sarcoma 1Other solid neoplasm 1Gynecologic 1Genitourinary 1CNS 1

Conditions

Sarcoma 76Gastrointestinal Stromal Tumors 36Dendritic Cell Sarcoma, Interdigitating 22Glioblastoma 20Liposarcoma 19Gliosarcoma 19Neoplasms 18Leiomyosarcoma 16Bone Neoplasms 16Rhabdomyosarcoma 15Neoplasm Metastasis 15Lymphoma, Large B-Cell, Diffuse 15Burkitt Lymphoma 15Central Nervous System Neoplasms 14Sarcoma, Synovial 13Recurrence 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Osteosarcoma 13Hemangiosarcoma 12Fibrosarcoma 12Multiple Myeloma 11Lymphoma, Non-Hodgkin 11Lymphoma, Mantle-Cell 11Lymphoma, Large-Cell, Immunoblastic 11Lymphoma, Follicular 11Lymphoma, B-Cell, Marginal Zone 11Lymphoma 11Leukemia, Myeloid, Chronic-Phase 11Leukemia, Myeloid, Acute 11Leukemia, Myeloid, Accelerated Phase 11

Interventions

sodium thiosulfate 1Restraint, Physical 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Liver Neoplasms × Sarcoma × Clear all
NCT00716976 2023-11-09

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Children's Oncology Group

Phase 3 Completed
131 enrolled 18 charts 1 FDA
CNSGastrointestinalGenitourinaryGynecologicSarcoma

Ovarian Germ Cell Cancer, Ototoxicity, Brain Neoplasms, Liver Neoplasms, Medulloblastoma, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡